News

Blood substitute: we have submitted an application to the DIANA NATO Accelerator

We have reapplied to the Defense Innovation Accelerator for the North Atlantic (DIANA) for our innovative synthetic blood substitute respirocyte proje…

Aptamers – a new chapter at NanoGroup

At NanoGroup, we believe in bold steps that revolutionize medicine. The acquisition of the aptamer platform from Pure Biologics is just such a&nb…

NanOX Recovery Box – status and schedule for certification

The NanOX Recovery Box is an innovative device for kidney perfusion outside the human body. Developed as part of the NanOX System, it provides a way t…

NanoGroup acquires DOTO MEDICAL and aptamer platform, strengthening position in biotechnology

NanoGroup S.A. has finalized the strategic acquisition of 100% of the shares in DOTO MEDICAL sp. z o.o. and full rights to the innovative aptamer…

NanoGroup S.A. member of the American Chamber of Commerce in Poland

We are pleased to announce that NanoGroup S.A. has joined the American Chamber of Commerce in Poland (AmCham). AmCham is an association that play…

NanoGroup S.A.’s potential investment in Auxilius Pharma – letter of intent signed

NanoGroup S.A. and Auxilius Pharma, a company specializing in the development of value-added medicines (value added medicines), have signed a let…

Media resources

Company logo

logotype.zip (1.27 MB)
Download
pp-thumbnail